JP2019525899A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019525899A5 JP2019525899A5 JP2018564979A JP2018564979A JP2019525899A5 JP 2019525899 A5 JP2019525899 A5 JP 2019525899A5 JP 2018564979 A JP2018564979 A JP 2018564979A JP 2018564979 A JP2018564979 A JP 2018564979A JP 2019525899 A5 JP2019525899 A5 JP 2019525899A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- formula
- composition
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 27
- 239000000203 mixture Substances 0.000 claims 10
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 150000001720 carbohydrates Chemical class 0.000 claims 3
- 235000005911 diet Nutrition 0.000 claims 3
- 230000037213 diet Effects 0.000 claims 3
- 150000002576 ketones Chemical class 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 2
- 208000009304 Acute Kidney Injury Diseases 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims 1
- 201000010915 Glioblastoma multiforme Diseases 0.000 claims 1
- 201000005569 Gout Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- 206010061216 Infarction Diseases 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- 208000010577 Niemann-Pick disease type C Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000027190 Peripheral T-cell lymphomas Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 208000033626 Renal failure acute Diseases 0.000 claims 1
- 206010049771 Shock haemorrhagic Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 claims 1
- 208000031672 T-Cell Peripheral Lymphoma Diseases 0.000 claims 1
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 1
- 208000007930 Type C Niemann-Pick Disease Diseases 0.000 claims 1
- 201000011040 acute kidney failure Diseases 0.000 claims 1
- 206010069351 acute lung injury Diseases 0.000 claims 1
- 206010064930 age-related macular degeneration Diseases 0.000 claims 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 201000007241 cutaneous T cell lymphoma Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 230000001037 epileptic effect Effects 0.000 claims 1
- 238000002637 fluid replacement therapy Methods 0.000 claims 1
- 208000005017 glioblastoma Diseases 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 230000007574 infarction Effects 0.000 claims 1
- 235000020887 ketogenic diet Nutrition 0.000 claims 1
- 208000002780 macular degeneration Diseases 0.000 claims 1
- 208000020968 mature T-cell and NK-cell non-Hodgkin lymphoma Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 201000005962 mycosis fungoides Diseases 0.000 claims 1
- 208000031225 myocardial ischemia Diseases 0.000 claims 1
- 210000004165 myocardium Anatomy 0.000 claims 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 230000009529 traumatic brain injury Effects 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021174538A JP7479337B2 (ja) | 2016-06-07 | 2021-10-26 | ベータ－ヒドロキシブチレート及びブタンジオールの中鎖脂肪酸エステル並びに組成物、並びにそれを使用するための方法 |
| JP2023215845A JP2024028287A (ja) | 2016-06-07 | 2023-12-21 | ベータ－ヒドロキシブチレート及びブタンジオールの中鎖脂肪酸エステル並びに組成物、並びにそれを使用するための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662346975P | 2016-06-07 | 2016-06-07 | |
| US62/346,975 | 2016-06-07 | ||
| PCT/US2017/035826 WO2017213999A1 (en) | 2016-06-07 | 2017-06-02 | Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021174538A Division JP7479337B2 (ja) | 2016-06-07 | 2021-10-26 | ベータ－ヒドロキシブチレート及びブタンジオールの中鎖脂肪酸エステル並びに組成物、並びにそれを使用するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019525899A JP2019525899A (ja) | 2019-09-12 |
| JP2019525899A5 true JP2019525899A5 (enExample) | 2020-07-09 |
| JP7058610B2 JP7058610B2 (ja) | 2022-04-22 |
Family
ID=60578899
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018564979A Active JP7058610B2 (ja) | 2016-06-07 | 2017-06-02 | ベータ－ヒドロキシブチレート及びブタンジオールの中鎖脂肪酸エステル並びに組成物、並びにそれを使用するための方法 |
| JP2021174538A Active JP7479337B2 (ja) | 2016-06-07 | 2021-10-26 | ベータ－ヒドロキシブチレート及びブタンジオールの中鎖脂肪酸エステル並びに組成物、並びにそれを使用するための方法 |
| JP2023215845A Withdrawn JP2024028287A (ja) | 2016-06-07 | 2023-12-21 | ベータ－ヒドロキシブチレート及びブタンジオールの中鎖脂肪酸エステル並びに組成物、並びにそれを使用するための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021174538A Active JP7479337B2 (ja) | 2016-06-07 | 2021-10-26 | ベータ－ヒドロキシブチレート及びブタンジオールの中鎖脂肪酸エステル並びに組成物、並びにそれを使用するための方法 |
| JP2023215845A Withdrawn JP2024028287A (ja) | 2016-06-07 | 2023-12-21 | ベータ－ヒドロキシブチレート及びブタンジオールの中鎖脂肪酸エステル並びに組成物、並びにそれを使用するための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US10889538B2 (enExample) |
| EP (2) | EP4585270A3 (enExample) |
| JP (3) | JP7058610B2 (enExample) |
| KR (2) | KR102638807B1 (enExample) |
| CN (2) | CN114292190B (enExample) |
| AU (2) | AU2017278099B2 (enExample) |
| CA (1) | CA3026621A1 (enExample) |
| CO (1) | CO2018014167A2 (enExample) |
| IL (2) | IL263561B (enExample) |
| MX (2) | MX2021009806A (enExample) |
| RU (1) | RU2761829C2 (enExample) |
| SG (1) | SG11201810765PA (enExample) |
| WO (1) | WO2017213999A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114292190B (zh) | 2016-06-07 | 2025-04-11 | J大卫格莱斯顿研究机构 | 丁二醇的中链脂肪酸酯，其组合物、口服制剂及其应用方法 |
| MX2020000734A (es) | 2017-07-21 | 2020-07-29 | Buck Inst Res Aging | Enantiómeros s de beta-hidroxibutirato y butanodiol, y métodos para usarlos. |
| WO2019147503A1 (en) | 2018-01-25 | 2019-08-01 | Buck Institute For Research On Aging | Synthesis of 3-hydroxybutyryl 3-hydroxybutyrate and related compounds |
| US20190248733A1 (en) * | 2018-02-14 | 2019-08-15 | Benjamin Bikman | Oral supplements of fatty acid and amino acid ketone esters to improve metabolic, physical and cognitive health |
| WO2020147983A1 (de) * | 2019-01-17 | 2020-07-23 | Ioi Oleo Gmbh | Verfahren zur herstellung von polyolbasierten estern von gegebenenfalls acylierten hydroxycarbonsäuren |
| WO2020147982A1 (de) * | 2019-01-17 | 2020-07-23 | Ioi Oleo Gmbh | Verfahren zur herstellung von fettalkoholestern von hydroxycarbonsäuren |
| JP7361124B2 (ja) * | 2019-01-17 | 2023-10-13 | ケトリピックス セラポーティクス ゲーエムベーハー | キャップされた３－ヒドロキシカルボン酸およびそれらの塩およびエステルの製造方法 |
| CN110372502A (zh) * | 2019-07-25 | 2019-10-25 | 润泰化学（泰兴）有限公司 | 一种1,3-二醇的双酯化合成方法 |
| GB201918657D0 (en) | 2019-12-17 | 2020-01-29 | Tdeltas Ltd | Compounds for new use |
| EP4146337B1 (de) * | 2020-07-13 | 2024-04-17 | KetoLipix Therapeutics GmbH | Verfahren zur herstellung von polyglycerinestern von mit oxobutanol veresterten polycarbonsäuren |
| BR112023000684A2 (pt) * | 2020-07-13 | 2023-01-31 | Ioi Oleo Gmbh | Método para produzir ésteres de oxobutanol de ácidos carboxílicos poliméricos |
| WO2022012766A1 (de) * | 2020-07-13 | 2022-01-20 | Ioi Oleo Gmbh | Verfahren zur herstellung von oxobutanol-estern von polymeren carbonsäuren |
| CN112341542B (zh) * | 2021-01-08 | 2021-05-14 | 清华大学 | 一种3-羟基丁酰化修饰蛋白质药物及其制备方法和应用 |
| CA3206310A1 (en) * | 2021-01-26 | 2022-08-04 | John C. Newman | Use of exogenous ketone esters to induce weight loss in mammals |
| US12059398B2 (en) * | 2022-08-26 | 2024-08-13 | Health Via Modern Nutrition Inc. | Compositions of 1,3-butanediol and beta-hydroxybutyric acid to provide optimal therapeutic ketosis |
| EP4483869A1 (en) | 2023-06-29 | 2025-01-01 | BOPZ nutrition Limited | Ketone esters for use in inducing ketosis in non-human mammals |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK85610C (da) | 1952-01-08 | 1958-05-27 | Unilever Nv | Fremgangsmåde til udvinding af fedstoffer af vandige sæbeopløsninger. |
| US4756907A (en) | 1978-10-17 | 1988-07-12 | Stolle Research & Development Corp. | Active/passive immunization of the internal female reproductive organs |
| US4263216A (en) * | 1978-10-20 | 1981-04-21 | The Procter & Gamble Company | Diglyceride manufacture |
| IL59407A (en) * | 1979-03-06 | 1983-12-30 | Sanofi Sa | Di-n-propylacetic acid diesters of glycerol,their preparation and pharmaceutical compositions containing them |
| US4436726A (en) | 1980-12-15 | 1984-03-13 | Fujisawa Pharmaceutical Co., Ltd. | N-Acylpeptide compound, processes for the preparation thereof and the pharmaceutical compositions |
| BE1001209A3 (fr) | 1987-11-19 | 1989-08-22 | Solvay | Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol. |
| US5126373A (en) | 1987-11-19 | 1992-06-30 | Henri Brunengraber | Composition for parenteral and oral nutrition |
| EP0633319B1 (en) | 1988-04-27 | 1999-03-17 | Daicel Chemical Industries, Ltd. | Process for producing optically active 1,3-butanediol |
| JP2578658B2 (ja) | 1989-02-21 | 1997-02-05 | チッソ株式会社 | 光学活性化合物及びその製造法 |
| US5008126A (en) | 1989-06-27 | 1991-04-16 | Nabisco Brands, Inc. | Long chain diol diesters as low calorie fat mimetics |
| IT1240760B (it) * | 1990-02-12 | 1993-12-17 | Sigma Tau Ind Farmaceuti | Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma. |
| DE69205560T2 (de) | 1992-01-08 | 1996-04-11 | Nestle Sa | Kosmetische und dermatologische Zusammensetzung, die Dioldiester enthält. |
| US5536249A (en) | 1994-03-09 | 1996-07-16 | Visionary Medical Products, Inc. | Pen-type injector with a microprocessor and blood characteristic monitor |
| US6146361A (en) | 1996-09-26 | 2000-11-14 | Becton Dickinson And Company | Medication delivery pen having a 31 gauge needle |
| DE19703471A1 (de) * | 1997-01-31 | 1998-08-06 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Triazinderivaten und Butylenglycoldiestern |
| CA2283642C (en) * | 1997-03-17 | 2012-05-15 | Btg International Limited | Therapeutic compositions |
| US6323237B1 (en) | 1997-03-17 | 2001-11-27 | Btg International Limited | Therapeutic compositions |
| AU733310C (en) * | 1997-05-14 | 2001-11-29 | University Of British Columbia, The | High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| US6197327B1 (en) | 1997-06-11 | 2001-03-06 | Umd, Inc. | Device and method for treatment of dysmenorrhea |
| US6096010A (en) | 1998-02-20 | 2000-08-01 | Becton, Dickinson And Company | Repeat-dose medication delivery pen |
| US6221053B1 (en) | 1998-02-20 | 2001-04-24 | Becton, Dickinson And Company | Multi-featured medication delivery pen |
| US6248095B1 (en) | 1998-02-23 | 2001-06-19 | Becton, Dickinson And Company | Low-cost medication delivery pen |
| DE60001686T2 (de) * | 1999-05-11 | 2003-08-21 | Dow Agrosciences Llc, Indianapolis | Verfahren zum Herstellen von substituierten 3-Hydroxybuttersäureester |
| US6277099B1 (en) | 1999-08-06 | 2001-08-21 | Becton, Dickinson And Company | Medication delivery pen |
| US6476079B1 (en) | 1999-12-23 | 2002-11-05 | Leiras Oy | Devices for the delivery of drugs having antiprogestinic properties |
| US20080009467A1 (en) | 2000-05-01 | 2008-01-10 | Accera, Inc. | Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism |
| CN101426763A (zh) * | 2000-10-11 | 2009-05-06 | 埃斯佩里安医疗公司 | 用于胆固醇治疗和相关应用的硫化物和二硫化物化合物和组合物 |
| EP1528053A1 (en) | 2003-10-31 | 2005-05-04 | Lonza Ag | Process for the preparation of (S)- or (R)-4-halo-3-hydroxybutyrates |
| JP2006063001A (ja) | 2004-08-25 | 2006-03-09 | Takasago Internatl Corp | 光学活性β−ブチロラクトンの製造方法 |
| CN101336233A (zh) * | 2005-12-07 | 2008-12-31 | 雷蒙特亚特特拉维夫大学有限公司 | 茉莉酮酸酯化学衍生物、其药物组合物及使用方法 |
| US7988883B2 (en) | 2006-02-10 | 2011-08-02 | Dupont Tate & Lyle Bio Products Company, Llc | Heat transfer compositions comprising renewably-based biodegradable 1,3-propanediol |
| US20100273824A1 (en) * | 2007-01-18 | 2010-10-28 | Evolva Sa | Substituted 1,3-dioxanes and their uses |
| JP5054418B2 (ja) * | 2007-04-23 | 2012-10-24 | ポーラ化成工業株式会社 | クレンジング用の化粧料に好適な皮膚外用剤 |
| US8642654B2 (en) | 2009-04-16 | 2014-02-04 | Isis Innovation Limited | Hydroxybutyrate ester and medical use thereof |
| EP3296284B1 (en) | 2008-08-21 | 2021-12-01 | The Government of the United States of America, as repres. by the Secretary of Health and Human Services, Nat. Inst. of Health | Non-therapeutical use of hydroxybutyrate ester |
| CA2760410A1 (en) | 2009-04-16 | 2010-10-21 | Isis Innovation Limited | Process for the preparation of (3r)-hydr0xybutyl (3r) -hydroxybutyrate by enzymatic enantioselective reduction employing lactobacillus brevis alcohol dehydrogenase |
| GB201002983D0 (en) | 2010-02-22 | 2010-04-07 | Tdeltas Ltd | Nutritinal composition |
| MX2012012390A (es) | 2010-04-28 | 2012-11-30 | Arkema Inc | Metodo para mejorar la estabilidad de mezclas de polioles poliuretanicos que contienen un agente de soplado olefinico halogenado. |
| KR101243240B1 (ko) * | 2010-07-19 | 2013-04-04 | (주)에이씨티 | 신규 알킬디올 유도체화합물 및 이를 포함하는 미백용 피부외용제조성물 |
| CN103360243B (zh) * | 2012-03-31 | 2015-06-17 | 中国石油化工股份有限公司 | 一种1,3-二酰氧基丙烷类化合物的制备方法 |
| KR101291441B1 (ko) | 2012-05-01 | 2013-07-30 | 코니카 미놀타 어드밴스드 레이어즈 인코포레이티드 | 위상차 필름, 편광판의 제조 방법 및 액정 표시 장치 |
| SG11201507685UA (en) | 2013-03-14 | 2015-10-29 | Isis Innovation | Process for producing (r)-3-hydroxybutyl (r)-3-hydroxybutyrate |
| KR102499654B1 (ko) | 2013-03-19 | 2023-02-13 | 유니버시티 오브 사우스 플로리다 | 상승되고 지속되는 케톤증을 생성하기 위한 조성물 및 방법 |
| US11814664B2 (en) | 2013-05-24 | 2023-11-14 | Genomatica, Inc. | Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate |
| ES2734209T3 (es) * | 2013-08-06 | 2019-12-04 | Imago Biosciences Inc | Inhibidores de KDM1A para el tratamiento de enfermedades |
| WO2016123229A1 (en) | 2015-01-29 | 2016-08-04 | Yale University | Compositions and methods for treating nlrp3 inflammasome-related diseases and disorders |
| US20180200220A1 (en) | 2015-07-10 | 2018-07-19 | Cognate Nutritionals, Inc. | Prophylaxis and mitigation of migraine headaches using ketogenic medium chain triglycerides, ketone esters, and other ketogenic sources |
| US10245242B1 (en) | 2017-11-22 | 2019-04-02 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| CN114292190B (zh) | 2016-06-07 | 2025-04-11 | J大卫格莱斯顿研究机构 | 丁二醇的中链脂肪酸酯，其组合物、口服制剂及其应用方法 |
| MX2020000734A (es) | 2017-07-21 | 2020-07-29 | Buck Inst Res Aging | Enantiómeros s de beta-hidroxibutirato y butanodiol, y métodos para usarlos. |
| WO2019147503A1 (en) | 2018-01-25 | 2019-08-01 | Buck Institute For Research On Aging | Synthesis of 3-hydroxybutyryl 3-hydroxybutyrate and related compounds |
| US20190262415A1 (en) | 2018-02-26 | 2019-08-29 | Ketologie LLC | Supplement for inducing and sustaining nutritional ketosis |
-
2017
- 2017-06-02 CN CN202111675586.8A patent/CN114292190B/zh active Active
- 2017-06-02 KR KR1020227044586A patent/KR102638807B1/ko active Active
- 2017-06-02 MX MX2021009806A patent/MX2021009806A/es unknown
- 2017-06-02 KR KR1020197000530A patent/KR102519244B1/ko active Active
- 2017-06-02 CN CN201780041428.2A patent/CN109477993B/zh active Active
- 2017-06-02 EP EP25179114.1A patent/EP4585270A3/en active Pending
- 2017-06-02 US US16/306,524 patent/US10889538B2/en active Active
- 2017-06-02 WO PCT/US2017/035826 patent/WO2017213999A1/en not_active Ceased
- 2017-06-02 MX MX2018015302A patent/MX385367B/es unknown
- 2017-06-02 JP JP2018564979A patent/JP7058610B2/ja active Active
- 2017-06-02 SG SG11201810765PA patent/SG11201810765PA/en unknown
- 2017-06-02 EP EP17810768.6A patent/EP3465335B1/en active Active
- 2017-06-02 RU RU2018143895A patent/RU2761829C2/ru active
- 2017-06-02 CA CA3026621A patent/CA3026621A1/en active Pending
- 2017-06-02 AU AU2017278099A patent/AU2017278099B2/en active Active
-
2018
- 2018-12-06 IL IL263561A patent/IL263561B/en unknown
- 2018-12-26 CO CONC2018/0014167A patent/CO2018014167A2/es unknown
-
2019
- 2019-07-29 US US16/525,437 patent/US10562839B2/en active Active
- 2019-07-31 US US16/528,524 patent/US10647658B2/en active Active
-
2020
- 2020-12-02 US US17/110,236 patent/US11608308B2/en active Active
-
2021
- 2021-06-07 AU AU2021203726A patent/AU2021203726C1/en active Active
- 2021-10-26 JP JP2021174538A patent/JP7479337B2/ja active Active
-
2022
- 2022-03-24 IL IL291694A patent/IL291694A/en unknown
-
2023
- 2023-12-21 JP JP2023215845A patent/JP2024028287A/ja not_active Withdrawn